This observation fuels the hypothesis that adjuvant radiotherapy could be omitted in small hormone receptor-positive, HER2-negative DCIS, especially when margin width is at least 2 mm [45]. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.